BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7299205)

  • 1. [Anticoagulation therapy in patients with valvular substitutes--survey of clotting factors and platelet aggregation for anticoagulation (author's transl)].
    Matsumoto H; Takayama T; Matsunaga H; Furuta N; Yoshitake T; Saigusa M
    Nihon Kyobu Geka Gakkai Zasshi; 1981 Jul; 29(7):1164-71. PubMed ID: 7299205
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulation in valvular heart disease preoperatively and postoperatively.
    Bodnar AG; Hutter AM
    Cardiovasc Clin; 1984; 14(3):247-64. PubMed ID: 6722854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation is necessary in all patients with mechanical prostheses in sinus rhythm.
    Duveau D
    Z Kardiol; 1986; 75 Suppl 2():326-31. PubMed ID: 3727712
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
    Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
    Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term anticoagulant treatment in patients with total valvular prosthesis. Personal contribution (author's transl)].
    Cerri B; Bianchi G; Zampaglione G; Grasso S; Pesciatini F
    G Ital Cardiol; 1974; 4(6):687-92. PubMed ID: 4448341
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of hemorrhagic and thromboembolic complications in heart valve prosthesis].
    Pospelova EP; Stepanian EP; Shchurkalina TKh; Movsesian RA
    Grudn Khir; 1971; 13(1):49-51. PubMed ID: 5577527
    [No Abstract]   [Full Text] [Related]  

  • 7. Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
    Dale J; Nitter-Hauge S
    Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence of anticoagulation in patients with bioprostheses.
    Gherli T; Colli A; Nicolini F
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S88-9. PubMed ID: 15225014
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticoagulants in therapy of patients with heart valve prostheses].
    Mauro R; Calatola P
    Minerva Med; 1975 Apr; 66(25):1229-35. PubMed ID: 1134663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Valvular bioprostheses and anticoagulation].
    Chambaz IC; Nendaz M
    Rev Med Suisse; 2008 Oct; 4(175):2198-202. PubMed ID: 19024573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of platelet aggregation under estrogen-treatment in patients with carcinoma of the prostate (author's transl)].
    Eisen M; Napp HE; Vock R
    Urologe A; 1975 May; 14(3):132-6. PubMed ID: 1154559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clotting properties in diverse valve prostheses.
    Zöller H; Gross W; Rieke K
    Z Kardiol; 1986; 75 Suppl 2():338-40. PubMed ID: 3727715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemostaseological problems with artificial heart-valves (author's transl)].
    Sutor AH; Fleissner-Busse G; Lehmann A; Hilgenberg F
    Z Kardiol; 1978 Dec; 67(12):852-6. PubMed ID: 735293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanical or biological prostheses in valvular substitutes (author's transl)].
    Menasché P; Bercot M; Piwnica A
    Ann Cardiol Angeiol (Paris); 1981 Dec; 30(7):501-6. PubMed ID: 7332260
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
    Colli A; Verhoye JP; Leguerrier A; Gherli T
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):573-7. PubMed ID: 17317197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet factor 4 in congenital haemostatic disorders (author's transl)].
    Domingo albos A; Ortega Aramburu J; Castillo Cofino R; Domenech Mateu MD
    Sangre (Barc); 1976; 21(2):243-50. PubMed ID: 948776
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anticoagulation after heart valve bioprosthesis].
    Hamm CW
    Dtsch Med Wochenschr; 1991 Mar; 116(13):514. PubMed ID: 2007385
    [No Abstract]   [Full Text] [Related]  

  • 18. Valve surgery: indications and long-term results.
    Usher BW
    Curr Opin Cardiol; 1991 Apr; 6(2):219-24. PubMed ID: 10149582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral anticoagulants and platelet function in hypolipemic therapy using a new clofibrate analog (BM 15.075) (author's transl)].
    Zimmermann R; Hoffrichter A; Walter E; Ehlers W; Andrassy K; Lang PD; Schlierf G; Weber E; Barth P
    Dtsch Med Wochenschr; 1977 Apr; 102(14):509-12. PubMed ID: 852404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sub-dural hematoma, complication of anti-coagulants for valvular mechanical protheses. Role of heterografts (author's transl)].
    Barra JA; Kretz JG; Grondin P
    Ann Cardiol Angeiol (Paris); 1979; 28(3):163-5. PubMed ID: 507720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.